Running separate protocols for multiple investigational products and disease subpopulations slows development and duplicates infrastructure. There is growing interest in accelerating drug development ...
Via well-designed AI tools and workflows, trial sponsors are aiming to unify cross-functional data ecosystems to enable a ...
Children who are deaf or hard of hearing may experience higher rates of adverse childhood experiences (ACEs) than their ...
Widely used eye ointments can cause glaucoma implants to swell and potentially rupture, according to new research from Nagoya ...
Widely used eye ointments can cause glaucoma implants to swell and potentially rupture, according to new research from Nagoya ...
Medable Inc., the leading technology platform for AI-powered clinical development, today announced its TMF Agent, which brings artificial intelligence and automation to the labor-intensive processes ...
Inga Farafontova, a Community Psychiatric Nurse in the Older Adult Community Mental Health Team, is on secondment at Oxford Brain Health Clinic (OBHC) as a Research Assistant, wor ...
Agentic AI is moving beyond automation to actively manage clinical complexity, streamline patient journeys and expand access ...
The Pathway Fellowship at Mayo Clinic in Florida is geared toward senior-level U.S. medical students who are focused on ...
Aragen Launches CHOMax™, an Accelerated Platform for DNA to IND-Enabling Clinical Supply in ~10 MonthsAccelerated pathway: ...
A common eye ointment may quietly damage glaucoma implants—sometimes to the point of rupture—by making them swell from the ...
Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a diversified developmental stage biopharmaceutical and cryptocurrency treasury company focused on developing novel formulations and drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback